The high mutation burden observed in genes strongly suggests a potential interplay between PI3K-Akt-mTOR signaling and ECM, contributing to tumor cell function and the establishment of a tumor-supportive microenvironment in IECs. The gene discussed is MTOR; the disease is neoplasm.